Summary
- Current Price
- As of today, RCUS price is $26.05, up +1.44% on
- Current Price All-Time High
- RCUS price is currently -46.95% below its historical high of $49.10 set on
- Market Cap
- RCUS current market cap is $3B, up +245.72% over the past 365 days
- PE Ratio
- RCUS PE ratio is unknown
- Revenue
- RCUS current annual revenue is $247.00M, down -4.26% year-over-year
- Next Earnings
- The next earnings release for RCUS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Arcus Biosciences, Inc. |
| Ticker | NYSE: RCUS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | arcusbio.com |
| Employees | 627 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $26.05 | |
| Price, 1D Change | +1.44% | |
| $3B | ||
| - | ||
| - | ||
| 1.94 | ||
| $247M | ||
| Revenue, 1Y Change | -4.26% | |
| -$3.29 | ||
| EPS, 1Y Change | -4.64% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.29 | ||
| EPS Estimate | N/A | -$3.65 |
| EPS Est. Change | N/A | -10.90% |
| $247.00M | ||
| Revenue Estimate | N/A | $91.20M |
| Revenue Est. Change | N/A | -63.08% |
| Current Price | $26.05 | |
| Price Target | - | $31.00 |
| Price Tgt. Change | - | +19.00% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.24 | -$3.14 | +3.07% | |
| -$3.50 | -$3.29 | +6.09% | |
| -$3.65 | N/A | -10.90% | |
| -$3.53 | N/A | -7.40% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $261.59M | $258.00M | -1.37% | |
| $237.60M | $247.00M | +3.96% | |
| $91.20M | N/A | -63.08% | |
| $109.53M | N/A | -55.66% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $26.05 | |
| $18.65 | ||
| SMA 200 vs Price | -28.39% | |
| $22.76 | ||
| SMA 50 vs Price | -12.65% | |
| 1.94 | ||
| $1.46 | ||
| 60.88 | ||
| 73.67% | ||
| 63.42% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $247.00M | ||
| -$3.29 | ||
| $237.00M | ||
| 95.95% | ||
| -$386.00M | ||
| -156.28% | ||
| -$353.00M | ||
| -142.92% | ||
| -$376.00M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.31 | ||
| 4.36 | ||
| 4.36 | ||
| - | ||
| 1 | ||
| 0.71 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 13.25 | ||
| 5.19 | ||
| -6.62 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $631.00M | ||
| $981.00M | ||
| $1.56B | ||
| $1.01B | ||
| $933.00M | ||
| $231.00M | ||
| $198.00M | ||
| $13.00M | ||
| $42.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $600.00M | ||
| $623.00M | ||
| $10.00M | ||
| $0.00 | ||
| $10.00M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$482.00M | ||
| $66.00M | ||
| $488.00M | ||
| $2.00M | ||
| -$484.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wedbush | → | |
| Citigroup | → | |
| Leerink Partners | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → | |
| Goldman Sachs | → | |
| Morgan Stanley | → | |
| HC Wainwright & Co. | → | |
| B of A Securities | → | |
| Goldman Sachs | → |
Analyst sentiment
Institutional ownership
Screeners with RCUS
FAQ
What is the ticker symbol for Arcus Biosciences, Inc.?
The ticker symbol for Arcus Biosciences, Inc. is NYSE:RCUS
Does Arcus Biosciences, Inc. pay dividends?
No, Arcus Biosciences, Inc. does not pay dividends
What sector is Arcus Biosciences, Inc. in?
Arcus Biosciences, Inc. is in the Healthcare sector
What industry is Arcus Biosciences, Inc. in?
Arcus Biosciences, Inc. is in the Biotechnology industry
What country is Arcus Biosciences, Inc. based in?
Arcus Biosciences, Inc. is headquartered in United States
When did Arcus Biosciences, Inc. go public?
Arcus Biosciences, Inc. initial public offering (IPO) was on March 15, 2018
Is Arcus Biosciences, Inc. in the S&P 500?
No, Arcus Biosciences, Inc. is not included in the S&P 500 index
Is Arcus Biosciences, Inc. in the NASDAQ 100?
No, Arcus Biosciences, Inc. is not included in the NASDAQ 100 index
Is Arcus Biosciences, Inc. in the Dow Jones?
No, Arcus Biosciences, Inc. is not included in the Dow Jones index
When was Arcus Biosciences, Inc. last earnings report?
Arcus Biosciences, Inc.'s most recent earnings report was on February 25, 2026
When does Arcus Biosciences, Inc. report earnings?
The next expected earnings date for Arcus Biosciences, Inc. is May 5, 2026
Data Sources & References
- RCUS Official Website www.arcusbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1724521/000172452126000009/0001724521-26-000009-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1724521/000172452126000009/0001724521-26-000009-index.htm
- RCUS Profile on Yahoo Finance finance.yahoo.com/quote/RCUS
- RCUS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rcus